Related Experiment Videos

Acute ischemic syndromes. Adjunctive therapy

Katherine A Littrell1, Karl B Kern

  • 1Genentech Cardiovascular Research, Inc., South San Francisco, California, USA. littrell@gene.com

Cardiology Clinics
|February 16, 2002
PubMed

Insights

This review covers adjunctive medications for acute coronary syndromes (ACS), a spectrum of acute myocardial ischemia. It details early, immediate, and subsequent management strategies in emergency cardiovascular care.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Pharmacology

Background:

  • Acute coronary syndromes (ACS) encompass a range of conditions from unstable angina to myocardial infarction.
  • ACS presents as a spectrum of clinical symptoms indicating acute myocardial ischemia.
  • Effective early management is critical for patient outcomes.

Purpose of the Study:

  • To review adjunctive medications used in the early management of ACS patients.
  • To categorize these therapies into immediate and subsequent treatment phases.
  • To provide an overview for emergency cardiovascular care settings.

Main Methods:

  • Literature review of adjunctive therapies for ACS.
  • Categorization of treatments based on timing of administration (immediate vs. subsequent).
  • Focus on medications used in the acute care setting.

Main Results:

  • Adjunctive medications are crucial for managing ACS.
  • Therapies are stratified into immediate interventions and ongoing acute care management.
  • The review outlines specific drug classes and their roles.

Conclusions:

  • Timely and appropriate adjunctive medication is essential for ACS patient care.
  • A phased approach to treatment (immediate and subsequent) optimizes emergency cardiovascular interventions.
  • Understanding these therapies improves the management of acute myocardial ischemia.

Related Concept Videos